Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Lise

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Pharmacogenetics and Genomics|October 19, 2006
A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiationSalvatore Terrazzino, Marco Agostini, Salvatore Pucciarelli, et al.
Breast Cancer Research and Treatment|August 21, 2004
Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancerGiorgio Zavagno, Gian Luca De Salvo, Fernando Bozza, et al.
International Journal of Cancer|July 15, 2004
Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanomaSimone Mocellin, Paolo Del Fiore, Laura Guarnieri, et al.
World Journal of Surgery|October 1, 2004
True versus mild hyperthermia during isolated hepatic perfusion: effects on melphalan pharmacokinetics and liver functionPierluigi Pilati, Simone Mocellin, Carlo R Rossi, et al.
Clinical Colorectal Cancer|September 10, 2009
Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarkerMariaelena Pierobon, Valerie Calvert, Claudio Belluco, et al.
Clinical Colorectal Cancer|May 9, 2009
Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway BiomarkerMariaelena Pierobon, Valerie Calvert, Claudio Belluco, et al.
Cancer|March 20, 2002
Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I studyCarlo R Rossi, Mirto Foletto, Simone Mocellin, et al.
International Journal of Cancer|February 3, 2005
Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinomaAntonello D'Arrigo, Claudio Belluco, Alessandro Ambrosi, et al.
Cancer Biomarkers : Section a of Disease Markers|February 19, 2010
A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumorsMarco Agostini, Maria Vittoria Enzo, Luca Morandi, et al.
Annals of Surgical Oncology|June 28, 2007
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancerClaudio Belluco, Emanuel F Petricoin, Enzo Mammano, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Pharmacogenetics and Genomics|October 19, 2006
A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiationSalvatore Terrazzino, Marco Agostini, Salvatore Pucciarelli, et al.
Breast Cancer Research and Treatment|August 21, 2004
Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancerGiorgio Zavagno, Gian Luca De Salvo, Fernando Bozza, et al.
International Journal of Cancer|July 15, 2004
Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanomaSimone Mocellin, Paolo Del Fiore, Laura Guarnieri, et al.
World Journal of Surgery|October 1, 2004
True versus mild hyperthermia during isolated hepatic perfusion: effects on melphalan pharmacokinetics and liver functionPierluigi Pilati, Simone Mocellin, Carlo R Rossi, et al.
Clinical Colorectal Cancer|September 10, 2009
Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarkerMariaelena Pierobon, Valerie Calvert, Claudio Belluco, et al.
Clinical Colorectal Cancer|May 9, 2009
Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway BiomarkerMariaelena Pierobon, Valerie Calvert, Claudio Belluco, et al.
Cancer|March 20, 2002
Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I studyCarlo R Rossi, Mirto Foletto, Simone Mocellin, et al.
International Journal of Cancer|February 3, 2005
Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinomaAntonello D'Arrigo, Claudio Belluco, Alessandro Ambrosi, et al.
Cancer Biomarkers : Section a of Disease Markers|February 19, 2010
A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumorsMarco Agostini, Maria Vittoria Enzo, Luca Morandi, et al.
Annals of Surgical Oncology|June 28, 2007
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancerClaudio Belluco, Emanuel F Petricoin, Enzo Mammano, et al.
Pageof 7